- Home
- MAIA vs INUV Comparison
MAIA vs INUV Comparison
Compare MAIA & INUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- INUV
- Stock Information
- Founded
- MAIA 2018
- INUV N/A
- Country
- MAIA United States
- INUV United States
- Employees
- MAIA N/A
- INUV N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- INUV Advertising
- Sector
- MAIA Health Care
- INUV Consumer Discretionary
- Exchange
- MAIA Nasdaq
- INUV Nasdaq
- Market Cap
- MAIA 56.7M
- INUV 52.5M
- IPO Year
- MAIA 2022
- INUV N/A
- Fundamental
- Price
- MAIA $1.32
- INUV $3.17
- Analyst Decision
- MAIA
- INUV Strong Buy
- Analyst Count
- MAIA 0
- INUV 3
- Target Price
- MAIA N/A
- INUV $15.67
- AVG Volume (30 Days)
- MAIA 594.6K
- INUV 165.3K
- Earning Date
- MAIA 11-11-2025
- INUV 11-06-2025
- Dividend Yield
- MAIA N/A
- INUV N/A
- EPS Growth
- MAIA N/A
- INUV N/A
- EPS
- MAIA N/A
- INUV N/A
- Revenue
- MAIA N/A
- INUV $97,940,442.00
- Revenue This Year
- MAIA N/A
- INUV $25.37
- Revenue Next Year
- MAIA N/A
- INUV $16.24
- P/E Ratio
- MAIA N/A
- INUV N/A
- Revenue Growth
- MAIA N/A
- INUV 21.45
- 52 Week Low
- MAIA $1.27
- INUV $1.90
- 52 Week High
- MAIA $3.48
- INUV $7.90
- Technical
- Relative Strength Index (RSI)
- MAIA 34.23
- INUV 39.42
- Support Level
- MAIA $1.65
- INUV $3.10
- Resistance Level
- MAIA $1.97
- INUV $3.50
- Average True Range (ATR)
- MAIA 0.12
- INUV 0.22
- MACD
- MAIA -0.05
- INUV -0.04
- Stochastic Oscillator
- MAIA 4.45
- INUV 10.74
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About INUV Inuvo Inc.
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.